Semaglutide is sold as Ozempic to treat Type 2 diabetes and as Wegovy for obesity. Saxenda and Victoza contain liraglutide. Saxenda is for weight loss, while Victoza is for diabetes. Average ...

Victoza offers a second option in these cases, he added. Victoza is Novo Nordisk’s once-daily injectable GLP-1 agonist and made around $3.6 billion in sales last year, making it the top-selling ...

More than 20% of boys and men in Canada and the US meet the diagnostic criteria for an eating disorder, latest evidence has shown. Researchers are now campaigning for greater awareness, inclusive ...

It included the injections semaglutide - known by its brand names Ozempic or Wegovy, liraglutide - also known as Victoza, exenatide - also known as Byetta or Bydureon, and dulaglutide also known ...

Following a Mediterranean diet is an “effective, cost-efficient lifestyle approach” to reducing the burden of autoimmune disorders, new research has demonstrated. A recent study has found that a ...

One of the earlier drugs that was approved in this class was Victoza. Later on, it also became FDA approved for weight loss, and the chemical drug itself was branded with a different name and ...

Novo’s total GLP-1 sales, which also includes figures from the type 2 diabetes drugs Victoza and Rybelsus, came in at just under DKK 39.6 billion ($6 billion).

The GLP-1 drug market is booming, fueled by their success in treating diabetes and obesity. Yet, this growth has unleashed a torrent of litigation — patent disputes, regulatory battles, and clashes ...